# Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

> **NCT02080195** · PHASE1,PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 1 (actual)

## Conditions studied

- Lupus Erythematosus
- Graft-versus-host Disease

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Rabbit antithymocyte globulin
- **RADIATION:** Total body irradiation
- **BIOLOGICAL:** Allogeneic bone marrow transplant

## Key facts

- **NCT ID:** NCT02080195
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-13
- **Primary completion:** 2017-03-28
- **Final completion:** 2017-03-29
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study was unable to accrue subjects
- **Last updated:** 2019-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080195, "Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02080195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*